PA
XERS icon

Perceptive Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

Perceptive Advisors’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7M Buy
+467,013
New +$2.98M 0.06% 98
2018
Q4 		– Sell
-200,627
Closed -$3.53M – 125
2018
Q3 		$3.53M Sell
200,627
-249,373
-55% -$5.41M 0.09% 77
2018
Q2 		$8.54M Buy
+450,000
New +$8.74M 0.22% 62

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Perceptive Advisors's XERS Position: Q2 2026 in Review

Perceptive Advisors opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 467,013 shares worth $3.7M. The stake represents 0.06% of the portfolio and ranks #98 among its holdings. This is a return to the name: Perceptive Advisors previously reported a position in XERS as recently as Q3 2018.

Perceptive Advisors first reported a position in XERS in Q2 2018 and has held it in 3 quarters since. The position peaked at $8.54M in Q2 2018. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Perceptive Advisors held 467,013 shares of Xeris Biopharma Holdings worth $3.7M as of Q2 2026.
  • Xeris Biopharma Holdings was a new Perceptive Advisors position in Q2 2026.
  • Xeris Biopharma Holdings made up 0.06% of Perceptive Advisors's portfolio in Q2 2026, its #98 holding.
  • Perceptive Advisors first reported a position in Xeris Biopharma Holdings in Q2 2018 and has held it in 3 quarters since.
  • Perceptive Advisors's Xeris Biopharma Holdings position peaked at $8.54M in Q2 2018.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.